Literature DB >> 11564685

The regulation of MAPKs in Y1 mouse adrenocortical tumor cells.

T Le1, B P Schimmer.   

Abstract

The regulation of the MAPKs, Erk(1) and Erk(2), and the MAPK kinase, Mek, were examined in the Y1 mouse adrenocortical tumor cell line and in the protein kinase A-defective mutant, Kin-8. ACTH and basic fibroblast growth factor each increased Mek phosphorylation and stimulated Mek activity in both cell lines and also activated the Erks at concentrations that paralleled their effects on Mek. The specific Mek inhibitor, PD98059, blocked the activation of the Erks by ACTH and basic fibroblast growth factor, indicating that Mek is the upstream activator of Erk. PD98059 did not block the phosphorylation of Mek, as might have been expected from previous studies; instead PD98059 inhibited the activity of the activated enzyme. In ACTH-stimulated, mutant Kin-8 cells, PD98059 paradoxically increased the amount of phosphorylated Mek, while preventing the activation of Erk. These results are interpreted as reflecting the loss of a protein kinase A-mediated inhibitory influence on Mek phosphorylation and activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564685     DOI: 10.1210/endo.142.10.8441

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex.

Authors:  Colin Jefcoate
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

Review 3.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

4.  Expression of StAR and Key Genes Regulating Cortisol Biosynthesis in Near Term Ovine Fetal Adrenocortical Cells: Effects of Long-Term Hypoxia.

Authors:  Vladimir E Vargas; Dean A Myers; Kanchan M Kaushal; Charles A Ducsay
Journal:  Reprod Sci       Date:  2017-05-03       Impact factor: 3.060

5.  Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1.

Authors:  Marion Desclozeaux; Irina N Krylova; Florence Horn; Robert J Fletterick; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

6.  Extracellular signal-regulated kinases (ERK1/2) signaling pathway plays a role in cortisol secretion in the long-term hypoxic ovine fetal adrenal near term.

Authors:  Vladimir E Vargas; Kanchan M Kaushal; Tshepo R Monau; Dean A Myers; Charles A Ducsay
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-20       Impact factor: 3.619

7.  SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.

Authors:  Lei Cai; Ailing Ji; Frederick C de Beer; Lisa R Tannock; Deneys R van der Westhuyzen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 8.  Regulation of adrenocortical steroid hormone production by RhoA-diaphanous 1 signaling and the cytoskeleton.

Authors:  Marion B Sewer; Donghui Li
Journal:  Mol Cell Endocrinol       Date:  2012-11-24       Impact factor: 4.102

9.  The role of specific mitogen-activated protein kinase signaling cascades in the regulation of steroidogenesis.

Authors:  Pulak R Manna; Douglas M Stocco
Journal:  J Signal Transduct       Date:  2011-01-05

10.  cAMP-stimulated phosphorylation of diaphanous 1 regulates protein stability and interaction with binding partners in adrenocortical cells.

Authors:  Donghui Li; Eric B Dammer; Natasha C Lucki; Marion B Sewer
Journal:  Mol Biol Cell       Date:  2013-01-16       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.